Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 466

1.

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial.

Adenis A, Blay JY, Bui-Nguyen B, Bouché O, Bertucci F, Isambert N, Bompas E, Chaigneau L, Domont J, Ray-Coquard I, Blésius A, Van Tine BA, Bulusu VR, Dubreuil P, Mansfield CD, Acin Y, Moussy A, Hermine O, Le Cesne A.

Ann Oncol. 2014 Jul 25. pii: mdu237. [Epub ahead of print]

PMID:
25122671
[PubMed - as supplied by publisher]
2.

Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience.

Frezza AM, Benson C, Judson IR, Litiere S, Marreaud S, Sleijfer S, Blay JY, Dewji R, Fisher C, van der Graaf W, Hayward L.

Clin Sarcoma Res. 2014 Jul 29;4:7. doi: 10.1186/2045-3329-4-7. eCollection 2014.

PMID:
25089183
[PubMed]
Free PMC Article
3.

Lack of correlation of BTNL2 polymorphism and cancer risk in sarcoidosis. BTNL2 and cancer risk in sarcoidosis.

Gaillot-Drevon M, Calender A, Blay JY, Valeyre D, Israel-Biet D, Roy P, Pacheco Y.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 8;31(2):136-41.

PMID:
25078641
[PubMed - in process]
4.

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

Chakiba C, Lagarde P, Pissaloux D, Neuville A, Brulard C, Pérot G, Coindre JM, Terrier P, Ranchere-Vince D, Ferrari A, Collini P, Suurmeijer AJ, Blay JY, Aarab Terrisse S, Piperno-Neumann S, Averous G, Bui B, Orbach D, Italiano A, Chibon F.

Ann Oncol. 2014 Jul 28. pii: mdu362. [Epub ahead of print]

PMID:
25070544
[PubMed - as supplied by publisher]
5.

Guidelines for time-to-event endpoint definitions in sarcomas and gastro-intestinal stromal tumors (GIST) trials. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

Bellera CA, Penel N, Ouali M, Bonvalot S, Casalli PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin R, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijder S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S.

Ann Oncol. 2014 Jul 28. pii: mdu360. [Epub ahead of print] Review.

PMID:
25070543
[PubMed - as supplied by publisher]
6.

Going further in the knowledge of Yondelis(®); what's new in clinical trials?

Blay JY.

Future Oncol. 2014 Jun;10(8 Suppl):s7-s12. doi: 10.2217/fon.14.114.

PMID:
25048046
[PubMed - in process]
7.

Going further in the knowledge of Yondelis(®); what's new in daily clinical practice?

Blay JY.

Future Oncol. 2014 Jun;10(8 Suppl):s13-7. doi: 10.2217/fon.14.115.

PMID:
25048044
[PubMed - in process]
8.

Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting.

Italiano A, Le Cesne A, Mendiboure J, Blay JY, Piperno-Neumann S, Chevreau C, Delcambre C, Penel N, Terrier P, Ranchere-Vince D, Lae M, Le Guellec S, Michels JJ, Robin YM, Bellera C, Bonvalot S.

Cancer. 2014 Jul 10. doi: 10.1002/cncr.28885. [Epub ahead of print]

PMID:
25042799
[PubMed - as supplied by publisher]
9.

Targeted polytherapy in small cell sarcoma and its association with doxorubicin.

Dumont SN, Yang D, Dumont AG, Reynoso D, Blay JY, Trent JC.

Mol Oncol. 2014 Jun 10. pii: S1574-7891(14)00123-9. doi: 10.1016/j.molonc.2014.05.016. [Epub ahead of print]

PMID:
24998445
[PubMed - as supplied by publisher]
10.

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG).

Duffaud F, Meeus P, Bachet JB, Cassier P, Huynh TK, Boucher E, Bouché O, Moutardier V, le Cesne A, Landi B, Marchal F, Bay JO, Bertucci F, Spano JP, Stoeckle E, Collard O, Chaigneau L, Isambert N, Lebrun-Ly V, Mancini J, Blay JY, Bonvalot S.

Eur J Surg Oncol. 2014 May 28. pii: S0748-7983(14)00430-2. doi: 10.1016/j.ejso.2014.04.011. [Epub ahead of print]

PMID:
24994075
[PubMed - as supplied by publisher]
11.

Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-up.

Toulmonde M, Le Cesne A, Mendiboure J, Blay JY, Piperno-Neumann S, Chevreau C, Delcambre C, Penel N, Terrier P, Ranchère-Vince D, Lae M, Le Guellec S, Michels JJ, Robin YM, Bellera C, Italiano A.

Cancer. 2014 Jun 18. doi: 10.1002/cncr.28836. [Epub ahead of print]

PMID:
24942887
[PubMed - as supplied by publisher]
12.

[Oncogenes, tumor suppressor genes, and aneuploidy: the sum of the nuances].

Blay JY.

Bull Cancer. 2014 Apr;101(4):340. French. No abstract available.

PMID:
24918235
[PubMed - indexed for MEDLINE]
13.

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.

Cassier PA, Kantor G, Bonvalot S, Lavergne E, Stoeckle E, Le Péchoux C, Meeus P, Sunyach MP, Vaz G, Coindre JM, Linassier C, Labib A, Delcambre C, Bay JO, Leyvraz S, Dubergé T, Lagrange JL, Duret A, Blay JY.

Ann Oncol. 2014 Jun 8. pii: mdu202. [Epub ahead of print]

PMID:
24914041
[PubMed - as supplied by publisher]
14.

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, Abiraj K, Cassier PA, Sica A, Gomez-Roca C, de Visser KE, Italiano A, Le Tourneau C, Delord JP, Levitsky H, Blay JY, Rüttinger D.

Cancer Cell. 2014 Jun 16;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016. Epub 2014 Jun 2.

PMID:
24898549
[PubMed - in process]
15.

Optimizing treatment outcomes with regorafenib: personalized dosing and other strategies to support patient care.

Grothey A, George S, van Cutsem E, Blay JY, Sobrero A, Demetri GD.

Oncologist. 2014 Jun;19(6):669-80. doi: 10.1634/theoncologist.2013-0059. Epub 2014 May 12.

PMID:
24821824
[PubMed - in process]
16.

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study.

Pappo AS, Vassal G, Crowley JJ, Bolejack V, Hogendoorn PC, Chugh R, Ladanyi M, Grippo JF, Dall G, Staddon AP, Chawla SP, Maki RG, Araujo DM, Geoerger B, Ganjoo K, Marina N, Blay JY, Schuetze SM, Chow WA, Helman LJ.

Cancer. 2014 Aug 15;120(16):2448-56. doi: 10.1002/cncr.28728. Epub 2014 May 2.

PMID:
24797726
[PubMed - in process]
17.

The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors.

Cassier PA, Floquet A, Penel N, Derbel O, Bui N'guyen B, Guastalla JP, Pissaloux D, Treilleux I, Saba CE, Blay JY, Ray-Coquard I.

Ann Oncol. 2014 May;25(5):1074-5. doi: 10.1093/annonc/mdu045. Epub 2014 Mar 20. No abstract available.

PMID:
24651409
[PubMed - in process]
18.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Lancet Oncol. 2014 Apr;15(4):415-23. doi: 10.1016/S1470-2045(14)70063-4. Epub 2014 Mar 5.

PMID:
24618336
[PubMed - indexed for MEDLINE]
19.

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study.

Bachelot T, Garcia-Saenz JA, Verma S, Gutierrez M, Pivot X, Kozloff MF, Prady C, Huang X, Khosravan R, Wang Z, Cesari R, Tassell V, Kern KA, Blay JY, Lluch A.

BMC Cancer. 2014 Mar 7;14:166. doi: 10.1186/1471-2407-14-166.

PMID:
24606768
[PubMed - in process]
Free PMC Article
20.

Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.

Huynh TK, Meeus P, Cassier P, Bouché O, Lardière-Deguelte S, Adenis A, André T, Mancini J, Collard O, Montemurro M, Bompas E, Rios M, Isambert N, Cupissol D, Blay JY, Duffaud F.

BMC Cancer. 2014 Mar 5;14:156. doi: 10.1186/1471-2407-14-156.

PMID:
24597959
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk